Dr. Judy Ju-Yi Chen, MD

Dr. Chen practices at West Coast Retina in San Francisco, California.

Dr. Chen's NPI, 1265875611, was assigned on April 15, 2013. Dr. Chen graduated from Pritzker School of Medicine in 2012. Dr. Chen's California license number on file is A141948.

Dr. Chen's primary practice is West Coast Retina, at 1445 Bush St, San Francisco, CA 94109-5520. The practice phone is (415) 972-4600.

Dr. Chen's primary practice is West Coast Retina in San Francisco, California. Dr. Chen is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is Alameda Health System. Dmand AI also links Dr. Chen to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Chen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chen's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Chen treats.

CMS data shows 34,858 Medicare services from Dr. Chen across 13 procedure codes in 2024, for 1,079 Medicare patients. Medicare paid $2,800,284 for them. Every service was in an office.

CMS counts 1,079 Medicare patients who saw Dr. Chen in 2024. The largest group is 75 to 84, with 441 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 73, with 49% women.

In 2024, Dr. Chen wrote 304 Medicare Part D claims for 97 patients. 63% of them were for generic drugs. CMS names the drug for 240 of them, across 10 drugs with 11 or more claims each, at $11,466 in total drug cost. In 2023, CMS named 230 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Chen, published from 2014 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Retinal Diseases, Tomography, Optical Coherence and Visual Acuity. Dr. Chen has published most often in Retin Cases Brief Rep. Dr. Chen's most frequent co-authors are Anita Agarwal, MD, Robert N. Johnson, MD and H. Richard McDonald, MD.

CMS Open Payments shows 107 general payments to Dr. Chen from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Genentech, Inc. paid the most, $13,454.

Dr. Chen graduated from Pritzker School of Medicine in 2012.

Dr. Chen is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.